Rating for MED
MEDIFAST INC (MED)
Last medifast inc earnings: 2/26 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.medifastnow.com
Company Research
Source: Benzinga
Impact Snapshot
Event Time:
MED
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MED alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MED alerts
High impacting MEDIFAST INC news events
Weekly update
A roundup of the hottest topics
MED
News
- Q3 Earnings Highlights: Medifast (NYSE:MED) Vs The Rest Of The Personal Care Stocks [Yahoo! Finance]Yahoo! Finance
- Nature's Sunshine (NATR) Q3 Earnings Report Preview: What To Look For [Yahoo! Finance]Yahoo! Finance
- Medifast Inc (MED) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... [Yahoo! Finance]Yahoo! Finance
- Medifast, Inc. (NYSE: MED) was upgraded by analysts at DA Davidson from an "underperform" rating to a "neutral" rating. They now have a $17.00 price target on the stock, up previously from $16.50.MarketBeat
- MED Q3 Earnings Beat, Revenues Fall on Customer Acquisition Challenges [Yahoo! Finance]Yahoo! Finance
MED
Earnings
- 11/4/24 - Beat
MED
Sec Filings
- 11/13/24 - Form SCHEDULE
- 11/4/24 - Form 10-Q
- 11/4/24 - Form 8-K
- MED's page on the SEC website